This is possibly due to the tumor-promoting roles of other serotonin receptors, such as HTR1D 42 and HTR7 43, that are slightly upregulated in OC (Figures S1B and S1D) and can activate the SRC signaling. The gene discussed is HTR1D; the disease is neoplasm.